UBS Downgrades Option Care Health to Neutral, Lowers Price Target to $32.05

Benzinga Newsdesk www.benzinga.com Negative 90.0%

Neg 90% Neu 0% Pos 0%

UBS analyst A.J. Rice downgrades Option Care Health (NASDAQ:OPCH) from Buy to Neutral and lowers the price target from $39 to $32.05.